IP Library Granted Patent US 10,301,604
Granted Patent B2
US 10,301,604 · App. 15/702,893 · Granted May 28, 2019

Engineered glucosyltransferases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,301,604
App. No.
15/702,893
Granted
May 28, 2019
Kind
B2
Abstract

Disclosed herein are glucosyltransferases with modified amino acid sequences. Such engineered enzymes exhibit improved alpha-glucan product yields and/or lower leucrose yields, for example. Further disclosed are reactions and methods in which engineered glucosyltransferases are used to produce alpha-glucan.

Claims (27)

1. A non-native glucosyltransferase comprising at least one amino acid substitution at a position corresponding with amino acid residue Ala-510 of SEQ ID NO:62

wherein the non-native glucosyltransferase synthesizes alpha-glucan comprising 1,3-linkages, and

wherein the non-native glucosyltransferase has:

(i) an alpha-glucan yield that is higher than the alpha-glucan yield of a second glucosyltransferase that only differs from the non-native glucosyltransferase at the substitution position(s), and/or

(ii) a leucrose yield that is lower than the leucrose yield of the second glucosyltransferase;

wherein the non-native glucosyltransferase comprises a catalytic domain that is at least about 90% identical to residues 55-960 of SEQ ID NO:4, residues 54-957 of SEQ ID NO:65, residues 55-960 of SEQ ID NO:30, residues 55-960 of SEQ ID NO:28, or residues 55-960 of SEQ ID NO:20.

2. The non-native glucosyltransferase of claim 1 , wherein the amino acid substitution at the position corresponding with amino acid residue Ala-510 is with a Glu, Ile, Val, or Asp residue.

3. The non-native glucosyltransferase of claim 1 , comprising two or more amino acid substitutions.

4. The non-native glucosyltransferase of claim 3 , wherein one of the two or more amino acid substitutions is at a position corresponding with amino acid residue Phe-607 of SEQ ID NO:62.

5. The non-native glucosyltransferase of claim 1 , wherein the alpha-glucan is insoluble and comprises at least about 50% alpha-1,3 linkages, and optionally wherein the alpha-glucan has a weight average degree of polymerization (DP w ) of at least 100.

6. The non-native glucosyltransferase of claim 1 , comprising a catalytic domain that is at least about 92% identical to residues 55-960 of SEQ ID NO:4, residues 54-957 of SEQ ID NO:65, residues 55-960 of SEQ ID NO:30, residues 55-960 of SEQ ID NO:28, or residues 55-960 of SEQ ID NO:20.

7. The non-native glucosyltransferase of claim 1 , comprising an amino acid sequence that is at least about 90% identical to SEQ ID NO:4, SEQ ID NO:65, SEQ ID NO:30, SEQ ID NO:28, or SEQ ID NO:20.

8. The non-native glucosyltransferase of claim 5 , wherein the non-native glucosyltransferase synthesizes insoluble alpha-1,3-glucan having at least about 90% alpha-1,3-linkages.

9. The non-native glucosyltransferase of claim 7 , comprising an amino acid sequence that is at least about 92% identical to SEQ ID NO:4, SEQ ID NO:65, SEQ ID NO:30, SEQ ID NO:28, or SEQ ID NO:20.

10. The non-native glucosyltransferase of claim 1 , wherein the alpha-glucan yield is at least about 10% higher than the alpha-glucan yield of the second glucosyltransferase.

11. A reaction composition comprising water, sucrose, and a non-native glucosyltransferase according to claim 1 .

12. A method of producing alpha-glucan comprising:

(a) contacting at least water, sucrose, and a non-native glucosyltransferase enzyme according to claim 1 , whereby alpha-glucan is produced; and

(b) optionally, isolating the alpha-glucan produced in step (a).

13. The non-native glucosyltransferase of claim 6 , comprising a catalytic domain that is at least about 93% identical to residues 55-960 of SEQ ID NO:4, residues 54-957 of SEQ ID NO:65, residues 55-960 of SEQ ID NO:30, residues 55-960 of SEQ ID NO:28, or residues 55-960 of SEQ ID NO:20.

14. The non-native glucosyltransferase of claim 13 , comprising a catalytic domain that is at least about 95% identical to residues 55-960 of SEQ ID NO:4, residues 54-957 of SEQ ID NO:65, residues 55-960 of SEQ ID NO:30, residues 55-960 of SEQ ID NO:28, or residues 55-960 of SEQ ID NO:20.

15. The non-native glucosyltransferase of claim 14 , comprising a catalytic domain that is at least about 96% identical to residues 55-960 of SEQ ID NO:4, residues 54-957 of SEQ ID NO:65, residues 55-960 of SEQ ID NO:30, residues 55-960 of SEQ ID NO:28, or residues 55-960 of SEQ ID NO:20.

16. The non-native glucosyltransferase of claim 15 , comprising a catalytic domain that is at least about 97% identical to residues 55-960 of SEQ ID NO:4, residues 54-957 of SEQ ID NO:65, residues 55-960 of SEQ ID NO:30, residues 55-960 of SEQ ID NO:28, or residues 55-960 of SEQ ID NO:20.

17. The non-native glucosyltransferase of claim 9 , comprising an amino acid sequence that is at least about 93% identical to SEQ ID NO:4, SEQ ID NO:65, SEQ ID NO:30, SEQ ID NO:28, or SEQ ID NO:20.

18. The non-native glucosyltransferase of claim 17 , comprising an amino acid sequence that is at least about 95% identical to SEQ ID NO:4, SEQ ID NO:65, SEQ ID NO:30, SEQ ID NO:28, or SEQ ID NO:20.

19. The non-native glucosyltransferase of claim 18 , comprising an amino acid sequence that is at least about 96% identical to SEQ ID NO:4, SEQ ID NO:65, SEQ ID NO:30, SEQ ID NO:28, or SEQ ID NO:20.

20. The non-native glucosyltransferase of claim 19 , comprising an amino acid sequence that is at least about 97% identical to SEQ ID NO:4, SEQ ID NO:65, SEQ ID NO:30, SEQ ID NO:28, or SEQ ID NO:20.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 28, 2020
From: DUPONT INDUSTRIAL BIOSCIENCES USA, LLC
To: NUTRITION & BIOSCIENCES USA 4, INC.
Reel/Frame 055028/0496 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENTITY TYPE PREVIOUSLY RECORDED AT REEL: 049879 FRAME: 0043. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 6, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT INDUSTRIAL BIOSCIENCES USA, LLC
Reel/Frame 050300/0408 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT INDUSTRIAL BIOSCIENCES USA, LLC
Reel/Frame 049879/0043 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2018
From: DANISCO US INC
To: E I DU PONT DE NEMOURS AND COMPANY
Reel/Frame 045421/0014 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2018
From: GENENCOR INTERNATIONAL B V
To: E I DU PONT DE NEMOURS AND COMPANY
Reel/Frame 045420/0973 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2018
From: LI, YOUGEN; HENNESSEY, SUSAN MARIE; PAYNE, MARK S; CHENG, QIONG; DICOSIMO, ROBERT; SEMKE, ELLEN D; PARKER, JARED B
To: E I DU PONT DE NEMOURS AND COMPANY
Reel/Frame 045250/0965 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2018
From: BOTT, RICHARD D
To: DANISCO US INC.
Reel/Frame 045251/0825 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2018
From: KRALJ, SLAVKO; ALKAN, VELI
To: GENENCOR INTERNATIONAL B.V.
Reel/Frame 045251/0042 →
Cited By (5)
US 12,188,055 US 12,389,916 US 12,486,338 US 12,618,051 US 12,715,981